Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$3,220.99 – $4,529.16
69% from low
Exchange
OTC Link
OS
GIVAUDAN AG
No one on the platform currently holds GVDBF.
No tracked institution reports a position in GVDBF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-24 | $72.0000 | 2026-03-25 |
| 2025-03-25 | $70.0000 | 2025-03-26 |
| 2024-03-25 | $68.0000 | 2024-03-27 |
No one on the platform has traded GVDBF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$GVDBF $SYIEF $IFF Cohen Milstein Investigates Givaudan, Symrise, International Flavors & Fragrances, Firmenich for Alleged Price-Fixing Antitrust Violations https://www.stocktitan.net/news/GVDBF/cohen-milstein-investigates-givaudan-symrise-international-flavors-lu5ldw7u9ejx.html
View on StockTwits ↗$GVDBF - About 17.0% of the company shares are held by… https://www.macroaxis.com/stock-analysis/GVDBF/Givaudan-SA #insidertrading #stocks #fintechnews
View on StockTwits ↗$GVDBF Does anyone know the ownership in the company of various members of the board at Givaudan (more specfically, does anyone own a significant amount?)
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $7.5B | -0.6% | $115.97 | $112.15–$118.35 | 35.6× | 6 |
| 2027 | $7.9B | +6.0% | $127.91 | $123.70–$130.54 | 32.2× | 7 |
| 2028 | $8.3B | +4.5% | $135.63 | $131.16–$138.42 | 30.4× | 4 |
| 2029 | $8.5B | +3.3% | $142.92 | $138.21–$145.85 | 28.9× | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-23 | $0.75 | $0.63 | -16.2% |
| 2026-01-29 | $0.71 | $0.69 | -3.7% |
| 2025-07-22 | $0.83 | $0.80 | -3.3% |
| 2025-01-24 | $0.64 | $0.60 | -7.1% |
| 2024-07-23 | $0.67 | $0.71 | +6.2% |
| 2024-01-25 | $0.59 | $0.61 | +3.2% |
| 2023-07-20 | $0.55 | $0.54 | -1.4% |
| 2023-01-25 | $44.36 |
| $49.36 |
| +11.3% |
| $30.1B |
| — |
| NVZMYNovozymes A/S | $65.61 | +2.21% | $30.6B | — |
Source: Financial Modeling Prep · peers by sector/industry